Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Glimfirst-M 2 Tablet PR

Prescription Icon
Prescription Required

Marketer

Sinsan Pharmaceuticals

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimfirst-M 2 Tablet PR

Diabexe Duo tablets are a dual-action antidiabetic medication used in adult patients with type 2 diabetes. This formulation combines two active components to effectively manage blood glucose levels. Diabexe Duo should be ingested with food, consistently at the same time daily for optimal results. Dosage is determined by your physician and may adjust based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision can lead to elevated blood sugar, increasing the risk of complications like kidney disease, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan that should include dietary changes, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headaches, and tremors. Learn to recognize these symptoms and treat them promptly with fast-acting glucose, such as sugary snacks or juice. Alcohol consumption increases hypoglycemia risk and should be limited. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headaches, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before starting Diabexe Duo. Pregnant or breastfeeding women require medical consultation prior to use. Regular blood glucose monitoring, along with periodic blood tests for complete blood count and liver function, are recommended.

Primary Ingredients of Glimfirst-M 2 Tablet PR

There is no text provided to rephrase.

Uses of Glimfirst-M 2 Tablet PR

Managing type 2 diabetes

Major Benefits of Glimfirst-M 2 Tablet PR:

Follow your doctor's instructions or the package insert for proper administration. Take Glimfirst-M 2 Tablet PR with a meal.

Common Side effects of Glimfirst-M 2 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimfirst-M 2 Tablet PR:

Follow your physician's instructions or refer to the product label for guidance. Administer Glimfirst-M 2 Tablet PR with a meal.

How Glimfirst-M 2 Tablet PR works:

Glimfirst-M 2 Tablet PR combines glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness in the body.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimfirst-M 2 Tablet PR and alcohol poses a significant safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimfirst-M 2 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Medical advice is recommended.

Breast feedingBreast feedingUNSAFE

The medication Glimfirst-M 2 Tablet PR is contraindicated for breastfeeding mothers due to the potential for infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimfirst-M 2 Tablet PR cautiously, potentially requiring dosage modification. Consult your physician. Glimfirst-M 2 Tablet PR is contraindicated in those with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimfirst-M 2 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician. A reduced starting dose is typically recommended for those with mild to moderate liver disease; its use is contraindicated in severe cases.

What if you forget to take Glimfirst-M 2 Tablet PR :

Should you forget a dose of Glimfirst-M 2 Tablet PR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimfirst-M 2 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimfirst-M 2 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Glimfirst-M 2 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glimfirst-M 2 Tablet PR and seek immediate medical attention.
Glimfirst-M 2 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood glucose control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. It's unsuitable for treating type 1 DM.
Glimfirst-M 2 Tablet PR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimfirst-M 2 Tablet PR use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, supplemental vitamin B12 is recommended annually by some researchers.
Glimfirst-M 2 Tablet PR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimfirst-M 2 Tablet PR and alcohol is unsafe. This combination can dangerously lower blood sugar, causing hypoglycemia, and increase the risk of lactic acidosis.
Glimfirst-M 2 Tablet PR
107
MRP 130
17% off